Biopharma companies face persistent hurdles in cell line development, including long timelines, low yields, and high failure rates for novel molecules
It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
Granite Bio's lead candidate is a novel monoclonal antibody for treatment of autoimmune and certain cancer indications. B
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
CHOMax integrates cell line development, process development, analytics, and GMP manufacturing under robust quality processes
The work will leverage ProBioGen’s CHO.RiGHT expression platform, powered by its proprietary DirectedLuck transposase technology, alongside PsiBot smart automation
The multi-partner team will integrate new technologies across the entire mAb production workflow, from cell line development to purification
Armlupeg is indicated for decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs
The antibody was designed and developed at Abzena’s Cambridge, UK,
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
